Mbx Biosciences, Inc. · NASDAQ:MBX
Frazier Life Sciences X, L.P. reported a 13.60% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Aug 18, 2025 · Filed Aug 20, 2025
Frazier Life Sciences X, L.P. reported a 13.60% stake in Mbx Biosciences, Inc., 4,552,774 shares, with active intent on Aug 18, 2025. Filed Aug 20, 2025 (Schedule 13D/A).
- Stake
- 13.60%
- Shares
- 4,552,774
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 17 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 3.30% | 1,103,920 |
| FHMLSP, L.P. | 3.30% | 1,103,920 |
| FHMLSP, L.L.C. | 3.30% | 1,103,920 |
| Frazier Life Sciences Public Overage Fund, L.P. | 1.00% | 325,653 |
| FHMLSP Overage, L.P. | 1.00% | 325,653 |
| FHMLSP Overage, L.L.C. | 1.00% | 325,653 |
| Frazier Life Sciences X, L.P. | 13.60% | 4,552,774 |
| FHMLS X, L.P. | 13.60% | 4,552,774 |
| FHMLS X, L.L.C. | 13.60% | 4,552,774 |
| Frazier Life Sciences XI, L.P. | 0% | 3,000 |
| FHMLS XI, L.P. | 0% | 3,000 |
| FHMLS XI, L.L.C. | 0% | 3,000 |
| James N. Topper | 13.60% | 4,552,774 |
| Patrick J. Heron | 13.60% | 4,557,097 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Mbx Biosciences, Inc.
- Frazier Life Sciences X, L.P.
- Mbx Biosciences, Inc. shareholders
- Schedule 13D/A · Frazier Life Sciences X, L.P. · Sep 30, 2025
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026